W STRATEGIES, LLC for ABBOTT LABORATORIES
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
FY 2018 Continuing resolution as it relates to suspension of the medical device tax. H.R.4617: Protect Medical Innovation Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Budget/Appropriations BUD
H.R.1892: Bipartisan Budget Act of 2018. H.R.1625: Consolidated Appropriations Act, 2018.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Medicare/Medicaid MMM
Medicare conditions of participation as it relates to antibiotics. Education about the regulation of continuous glucose monitor technologies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Health Issues HCR
Development of legislation regulated to regulation of LDT's, including a discussion draft of Diagnostic Accuracy and Improvement Act. Education about the importance of non-pharmacological pain treatment options, including medical devices. H.R.195, as it relates to the HEALTHY KIDS Act CHIP reauthorization.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.